AKT1 and chronic obstructive pulmonary disease: Based on network pharmacology, we consider that miRNAs may act as upstream regulators on corresponding signaling pathways, and the PI3K/AKT signaling pathway acts as a bridge in the regulatory network of naringenin in the treatment of COPD.